AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA or Agency) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Table 1—List of Information Collections Approved by OMB
| Title of collection | OMB control No. | Date approval expires |
|---|---|---|
| Blood Establishment Registration and Product Listing for Manufacturers of Blood and Blood Products and Licensed Devices | 0910-0052 | 7/31/2024 |
| Current Good Manufacturing Practice: Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Gases and Active Pharmaceutical Ingredients) | 0910-0139 | 7/31/2024 |
| Irradiation in the Production, Processing, and Handling of Food | 0910-0186 | 7/31/2024 |
| State Enforcement Notifications | 0910-0275 | 7/31/2024 |
| Veterinary Feed Directive | 0910-0363 | 7/31/2024 |
| Record Retention Requirements for the Soy Protein/Coronary Heart Disease Health Claim | 0910-0428 | 7/31/2024 |
| Prescription Drug Marketing: Administrative Procedures, Policies, and Requirements | 0910-0435 | 7/31/2024 |
| Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications | 0910-0796 | 7/31/2024 |
| Survey of Drug Product Manufacturing, Processing, and Packing Facilities | 0910-0899 | 7/31/2024 |
| Current Good Manufacturing Practices for Blood and Related Regulations for Blood Components; and Requirements for Donor Testing, Donor Notification and “Lookback” | 0910-0116 | 8/31/2024 |
| New Animal Drugs for Investigational Use | 0910-0117 | 8/31/2024 |
| Regulations Under the Federal Import Milk Act | 0910-0212 | 8/31/2024 |
| Medical Device Reporting | 0910-0437 | 8/31/2024 |
| New Plant Varieties Intended for Food Use | 0910-0583 | 8/31/2024 |
| Guidance for Industry and FDA Staff; Class II Special Controls: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle | 0910-0594 | 8/31/2024 |
| Prescription Drug Advertisements | 0910-0686 | 8/31/2024 |
| Animal Food Labeling; Declaration of Certifiable Color Additives | 0910-0721 | 8/31/2024 |
| Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Retail and Food Service Facility Types | 0910-0744 | 8/31/2024 |
| Food and Cosmetic Export Certificates | 0910-0793 | 8/31/2024 |
| National Agriculture and Food Defense Strategy Survey | 0910-0855 | 8/31/2024 |
| Medical Product Communications That are Consistent With the Food and Drug Administration Required Labeling—Questions and Answers | 0910-0856 | 8/31/2024 |
| Drug and Device Manufacturer Communications with Payors, Formulary Committees, and Similar Entities Questions and Answers | 0910-0857 | 8/31/2024 |
| Study of Disclosures to Health Care Providers Regarding Data That Do Not Support Unapproved Use of an Approved Prescription Drug | 0910-0900 | 8/31/2024 |
| Medical Conference Attendees' Observations About Prescription Drug Promotion | 0910-0901 | 8/31/2024 |
Dated: September 24, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-21386 Filed 9-30-21; 8:45 am]
BILLING CODE 4164-01-P